The Novo Nordisk Foundation has reaffirmed its commitment to focusing on non-communicable diseases, despite a growing crisis in global health funding caused by the U.S. halt on foreign aid. The foundation, closely linked to the Danish drugmaker, prioritizes tackling heart disease, diabetes, and obesity.
About the Author
